Literature DB >> 7548467

Early intervention for schizophrenia: can the course of the illness be altered?

R J Wyatt.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7548467     DOI: 10.1016/0006-3223(95)00191-I

Source DB:  PubMed          Journal:  Biol Psychiatry        ISSN: 0006-3223            Impact factor:   13.382


× No keyword cloud information.
  8 in total

Review 1.  Rationale for the study of early intervention.

Authors:  R J Wyatt; I Henter
Journal:  Schizophr Res       Date:  2001-08-01       Impact factor: 4.939

Review 2.  Animal models of schizophrenia: a critical review.

Authors:  E R Marcotte; D M Pearson; L K Srivastava
Journal:  J Psychiatry Neurosci       Date:  2001-11       Impact factor: 6.186

3.  Ethical concerns in schizophrenia research: looking back and moving forward.

Authors:  Scott T Wilson; Barbara Stanley
Journal:  Schizophr Bull       Date:  2005-11-10       Impact factor: 9.306

4.  Improving mental health care for children and adolescents: a role for prevention science.

Authors:  Stephen V Faraone
Journal:  World Psychiatry       Date:  2005-10       Impact factor: 49.548

5.  Relapse duration, treatment intensity, and brain tissue loss in schizophrenia: a prospective longitudinal MRI study.

Authors:  Nancy C Andreasen; Dawei Liu; Steven Ziebell; Anvi Vora; Beng-Choon Ho
Journal:  Am J Psychiatry       Date:  2013-06       Impact factor: 18.112

Review 6.  Augmentation strategies in clozapine-resistant schizophrenia.

Authors:  Gary Remington; Amitabha Saha; Siow-Ann Chong; Chekkera Shammi
Journal:  CNS Drugs       Date:  2005       Impact factor: 5.749

Review 7.  Conventional versus novel antipsychotics: changing concepts and clinical implications.

Authors:  G Remington; S A Chong
Journal:  J Psychiatry Neurosci       Date:  1999-11       Impact factor: 6.186

8.  Conceptualization of the liability for schizophrenia: clinical implications.

Authors:  M T Tsuang; W S Stone; S V Faraone
Journal:  Dialogues Clin Neurosci       Date:  1999-12       Impact factor: 5.986

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.